Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
AstraZeneca
Johnson and Johnson
QuintilesIMS
Citi
Farmers Insurance
US Army
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has six approved drugs.



Summary for Ingenus Pharms Llc
US Patents:0
Tradenames:6
Ingredients:6
NDAs:6

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 208487-002 Apr 26, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ingenus Pharms Llc CLOBETASOL PROPIONATE clobetasol propionate AEROSOL, FOAM;TOPICAL 206805-001 Jul 31, 2017 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ingenus Pharms Llc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-004 Dec 26, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 208487-001 Apr 26, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
McKesson
Healthtrust
Johnson and Johnson
Julphar
Queensland Health
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.